Effects of IMT on Cardiac Resynchronization Therapy

NCT ID: NCT07035340

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-15

Study Completion Date

2025-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who are followed up in the cardiology clinic with a diagnosis of CHF, who have had a CRT implant at least 1 year ago, and who do not receive cardiac rehabilitation will be included. The aim of the study is to investigate the effects of inspiratory muscle training (IMT) on exercise capacity, respiratory muscle strength, NTproBNP and quality of life.

Groups Intervention group: Treatment with IMT Control group: Standard care Study hypothesis;

1. Does IMT have an effect on exercise capacity and quality of life in patients with CRT?
2. Does IMT have an effect on NTproBNP in patients with CRT?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Resynchronization Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Doctor who doing ekogardiography.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

İntervention group

inspiratory muscle training

Group Type EXPERIMENTAL

inspiratory muscle training

Intervention Type OTHER

inspiratory muscle traning MIP%40-60

Control group

Standart care

Group Type OTHER

standart care

Intervention Type OTHER

standart care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

inspiratory muscle training

inspiratory muscle traning MIP%40-60

Intervention Type OTHER

standart care

standart care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were followed up in the cardiology clinic with a diagnosis of CHF,
* CRT implanted at least 1 year ago,
* did not receive cardiac rehabilitation,
* 45-75 years old,
* communicate in Turkish,
* NYHA II-III

Exclusion Criteria

* orthopedic and neurological disorders that may prevent walking,
* acute respiratory tract infection in the last month,
* NYHA I were not included in this study because they were generally not hospitalised and the problems were managed with outpatient diagnosis and treatment, and patients with class IV were not included in this study because they showed severe symptoms for medical and ethical reasons and they were not wanted to be forced with this long-lasting survey application process.
Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tarsus University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nurel Ertürk

Phd,PT

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tarsus University

Mersin, Mersin, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute IMT Intensity Effects in Male Smokers
NCT07200895 NOT_YET_RECRUITING NA